Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mick

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicityR Mick, E Gupta, E E Vokes, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 1, 1991
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapyR Mick, E E Vokes, R R Weichselbaum, et al.
Leukemia & Lymphoma|January 1, 1994
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986R T Spielberger, R Mick, M J Ratain, et al.
Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft functionL M Shaw, R Mick, I Nowak, et al.
Blood|February 7, 1998
In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopeniaM Z Ratajczak, J Ratajczak, B Machalinski, et al.
Hematological Oncology|January 1, 1988
Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observationC Shustik, R Mick, R Silver, et al.
Cancer Genetics and Cytogenetics|March 1, 1991
The proportion of abnormal karyotypes in acute leukemia samples related to method of preparationY S Li, M M Le Beau, R Mick, et al.
Breast Cancer Research and Treatment|January 1, 1989
Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies?R Mick, C B Begg, K H Antman, et al.
Journal of Virology|November 2, 2001
Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spreadJ Czarneski, J Meyers, T Peng, et al.
Blood|May 15, 1994
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessmentP Kampmeier, R Spielberger, J Dickstein, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicityR Mick, E Gupta, E E Vokes, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 1, 1991
Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapyR Mick, E E Vokes, R R Weichselbaum, et al.
Leukemia & Lymphoma|January 1, 1994
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986R T Spielberger, R Mick, M J Ratain, et al.
Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft functionL M Shaw, R Mick, I Nowak, et al.
Blood|February 7, 1998
In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopeniaM Z Ratajczak, J Ratajczak, B Machalinski, et al.
Hematological Oncology|January 1, 1988
Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observationC Shustik, R Mick, R Silver, et al.
Cancer Genetics and Cytogenetics|March 1, 1991
The proportion of abnormal karyotypes in acute leukemia samples related to method of preparationY S Li, M M Le Beau, R Mick, et al.
Breast Cancer Research and Treatment|January 1, 1989
Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies?R Mick, C B Begg, K H Antman, et al.
Journal of Virology|November 2, 2001
Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spreadJ Czarneski, J Meyers, T Peng, et al.
Blood|May 15, 1994
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessmentP Kampmeier, R Spielberger, J Dickstein, et al.
Pageof 13